Treatment decisions for advanced stages of breast cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists’ choices. This series of reports will allow you to see what is actually happening at the patient level for different types of patients presenting with a wide range of issues in advanced stages of cancer.
Primary research on the oncology prescribing data that you are missing, directly from high-prescribing US oncologists regarding metastatice breast cancer: what they prescribe, when, and why. Case highlights include:
This report allows you to: